Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, NY, NY, United States of America; Department of Obstetrics and Gynecology, Weill Cornell Medical College, NY, NY, United States of America.
Department of Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, NY, NY, United States of America.
Gynecol Oncol. 2022 Sep;166(3):417-424. doi: 10.1016/j.ygyno.2022.07.002. Epub 2022 Jul 22.
The Laparoscopic Approach to Cervical Cancer (LACC) trial found that minimally invasive radical hysterectomy compared to open radical hysterectomy compromised oncologic outcomes and was associated with worse progression-free survival (PFS) and overall survival (OS) in early-stage cervical carcinoma. We sought to assess oncologic outcomes at multiple centers between minimally invasive (MIS) radical hysterectomy and OPEN radical hysterectomy.
This is a multi-institutional, retrospective cohort study of patients with 2009 FIGO stage IA1 (with lymphovascular space invasion) to IB1 cervical carcinoma from 1/2007-12/2016. Patients who underwent preoperative therapy were excluded. Squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinomas were included. Appropriate statistical tests were used.
We identified 1093 cases for analysis-715 MIS (558 robotic [78%]) and 378. OPEN procedures. The OPEN cohort had more patients with tumors >2 cm, residual disease in the hysterectomy specimen, and more likely to have had adjuvant therapy. Median follow-up for the MIS and OPEN cohorts were 38.5 months (range, 0.03-149.51) and 54.98 months (range, 0.03-145.20), respectively. Three-year PFS rates were 87.9% (95% CI: 84.9-90.4%) and 89% (95% CI: 84.9-92%), respectively (P = 0.6). On multivariate analysis, the adjusted HR for recurrence/death was 0.70 (95% CI: 0.47-1.03; P = 0.07). Three-year OS rates were 95.8% (95% CI: 93.6-97.2%) and 96.6% (95% CI: 93.8-98.2%), respectively (P = 0.8). On multivariate analysis, the adjusted HR for death was 0.81 (95% CI: 0.43-1.52; P = 0.5).
This multi-institutional analysis showed that an MIS compared to OPEN radical hysterectomy for cervical cancer did not appear to compromise oncologic outcomes, with similar PFS and OS.
腹腔镜宫颈癌根治术(LACC)试验发现,与开放性根治性子宫切除术相比,微创手术根治性子宫切除术对肿瘤学结局不利,与早期宫颈癌患者无进展生存率(PFS)和总生存率(OS)更差有关。我们试图评估微创(MIS)根治性子宫切除术和开放性根治性子宫切除术之间多个中心的肿瘤学结果。
这是一项多机构、回顾性队列研究,纳入了 2009 年FIGO 分期 IA1(伴脉管间隙浸润)至 IB1 期宫颈癌患者,入组时间为 2007 年 1 月至 2016 年 12 月。排除术前接受治疗的患者。纳入鳞癌、腺癌和腺鳞癌患者。使用了适当的统计检验。
我们共纳入了 1093 例患者进行分析,其中 715 例行 MIS(558 例行机器人手术[78%]),378 例行开放性手术。开放性手术组的肿瘤>2cm、子宫切除标本中残留疾病和辅助治疗的患者更多。MIS 和开放性手术组的中位随访时间分别为 38.5 个月(范围:0.03-149.51)和 54.98 个月(范围:0.03-145.20)。3 年 PFS 率分别为 87.9%(95%CI:84.9-90.4%)和 89%(95%CI:84.9-92%)(P=0.6)。多因素分析显示,复发/死亡的调整 HR 为 0.70(95%CI:0.47-1.03;P=0.07)。3 年 OS 率分别为 95.8%(95%CI:93.6-97.2%)和 96.6%(95%CI:93.8-98.2%)(P=0.8)。多因素分析显示,死亡的调整 HR 为 0.81(95%CI:0.43-1.52;P=0.5)。
这项多机构分析表明,与开放性根治性子宫切除术相比,MIS 治疗宫颈癌似乎不会影响肿瘤学结局,两者的无进展生存率和总生存率相似。